1. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery 
P. Forget, C. Bentin, J.-P. Machiels, M. Berliere, P.G. Coulie, M. De Kock 
British Journal of Anaesthesia 
Volume 113, Pages i82-i87 (July 2014)
DOI: /bja/aet464
Copyright © 2014 The Author(s) Terms and Conditions

2. Fig 1
Study flow chart.
British Journal of Anaesthesia  , i82-i87DOI: ( /bja/aet464)
Copyright © 2014 The Author(s) Terms and Conditions

3. Fig 2
Kaplan–Meier curves of DFS for 720 patients receiving or not an intraoperative administration of NSAIDs (ketorolac or diclofenac) during conservative breast cancer surgery. Univariate analysis by log-rank test.
British Journal of Anaesthesia  , i82-i87DOI: ( /bja/aet464)
Copyright © 2014 The Author(s) Terms and Conditions

4. Fig 3
Kaplan–Meier curves of OS for 720 patients receiving or not an intraoperative administration of NSAIDs (ketorolac or diclofenac) during conservative breast cancer surgery. Univariate analysis by log-rank test.
British Journal of Anaesthesia  , i82-i87DOI: ( /bja/aet464)
Copyright © 2014 The Author(s) Terms and Conditions

5. Fig 4
Kaplan–Meier curves of DFS for 451 patients with an NLR >3.3, or not, before conservative breast cancer surgery. Univariate analysis by log-rank test.
British Journal of Anaesthesia  , i82-i87DOI: ( /bja/aet464)
Copyright © 2014 The Author(s) Terms and Conditions

6. Fig 5
Kaplan–Meier curves of OS for 451 patients with an NLR >3.3, or not, before conservative breast cancer surgery. Univariate analysis by log-rank test.
British Journal of Anaesthesia  , i82-i87DOI: ( /bja/aet464)
Copyright © 2014 The Author(s) Terms and Conditions